Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 4,4'-Bipyridine | HCID 11107 | — |
| Reactant | Cyclopropylboronic acid | HCID 2760897 | — |
| Reactant | HCID 135743575 | HCID 135743575 | — |
| Catalyst | Cuprous acetate | HCID 69023 | — |
| Solvent | 1,2-Dichloroethane | HCID 11 | — |
| Product | HCID 86728325 | HCID 86728325 | 54% |
Reaction Steps
A mixture of 7-chloro-2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one (300 mg, 1.75 mmol), cyclopropylboronic acid (300 mg, 3.50 mmol), 4,4′-bipyridine (273 mg, 1.75 mmol), copper (I) acetate (214 mg, 1.75 mmol) and Na2CO3 (371 mg, 3.50 mmol) in 1,2-dichloroethane (DCE) (20 mL) was stirred at 70° C. for 3 h and concentrated to remove solvent under vacuo. Purification via Biotage system with inverse phase column (water and acetonitrile as eluent) afforded the title product (200 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09051325B2 |
|---|
| Source dataset | uspto-grants-2015_06 |
|---|
| ORD ID | ord-e83dd41931ce4ff0a4f625fa64a1e067 |
|---|
| Source note | uspto-grants-2015_06 |
|---|